1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Thalassemia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Thalassemia Clinical Trials by Region
2.2.2 Average Enrollment of Thalassemia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Thalassemia Treatment, 2019

3. Region wise Thalassemia Clinical Trials
3.1 Asia Pacific Thalassemia Clinical Trials by Country
3.2 Europe Thalassemia Clinical Trials by Country
3.3 North America Thalassemia Clinical Trials by Country
3.4 Middle East and Africa Thalassemia Clinical Trials by Country
3.5 South and Central America Thalassemia Clinical Trials by Country

4. Thalassemia Clinical Trial Trends
4.1 Start Year wise Thalassemia Clinical Trials
4.2 Phase wise Thalassemia Clinical Trials
4.3 Trial Status wise Thalassemia Clinical Trials
4.4 Trial Type wise Thalassemia Clinical Trials

5. Thalassemia Average Enrollment Trends
5.1 Average Enrollment in Thalassemia Trials by Year
5.2 Average Enrollment in Thalassemia Trials by Phase
5.3 Average Enrollment in Thalassemia Trials by Status
5.4 Average Enrollment in Thalassemia Trials by Type of Trial

6. Companies Participating in Thalassemia Clinical Trials
6.1 Thalassemia Trials by Sponsor Type
6.2 Thalassemia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Thalassemia Trials- Phase 1
7.2 Thalassemia Trials- Phase 2
7.3 Thalassemia Trials- Phase 3
7.4 Thalassemia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Thalassemia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Thalassemia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Thalassemia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Thalassemia Clinical Trials and Enrolment
Figure 7: North America - Country wise Thalassemia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Thalassemia Clinical Trials and Enrolment
Figure 9: Thalassemia Clinical Trials by Phase
Figure 10: Thalassemia Clinical Trials by Trial Status
Figure 11: Thalassemia Clinical Trials by Type
Figure 12: Thalassemia Clinical Trials by Sponsor Type
Figure 13: Thalassemia Clinical Trials by Leading Sponsors
Figure 14: Thalassemia Average Enrollment by Phase
Figure 15: Thalassemia Average Enrollment by Trial Status
Figure 16: Thalassemia Average Enrollment by Type
Figure 17: Thalassemia- Average Enrolment by Type of Sponsors
Figure 18: Thalassemia- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Thalassemia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Thalassemia Clinical Trials and Enrolment
Table 5: Europe - Country wise Thalassemia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Thalassemia Clinical Trials and Enrolment
Table 7: North America - Country wise Thalassemia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Thalassemia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Thalassemia Average Enrollment by Phase
Table 15: Thalassemia Average Enrollment by Trial Status
Table 16: Thalassemia Average Enrollment by Type
Table 17: Thalassemia- Average Enrolment by Type of Sponsors
Table 18: Thalassemia- Enrolment by Leading Sponsors

Companies mentioned
Acceleron Pharma Inc, Apotex Inc, bluebird bio Inc, Celgene Corp, Emmaus Life Sciences Inc, GlaxoSmithKline Plc, HemaQuest Pharmaceuticals Inc, Novartis AG, Sanofi, Shire Plc